BACKGROUND: Breast capsular contracture is a major problem following implant-based breast reconstruction, particularly in the setting of radiation therapy. Recent work has identified a fibrogenic fibroblast subpopulation characterized by CD26 surface marker expression. OBJECTIVES: This work aimed to investigate the role of CD26-positive fibroblasts in the formation of breast implant capsules following radiation therapy. METHODS: Breast capsule specimens were obtained from irradiated and nonirradiated breasts of 10 patients following bilateral mastectomy and unilateral irradiation at the time of expander-implant exchange, under institutional review board approval. Specimens were processed for hematoxylin and eosin staining as well as for immunohistochemistry and fluorescence activated cell sorting for CD26-positive fibroblasts. Expression of fibrotic genes and production of collagen were compared between CD26-positive, CD26-negative, and unsorted fibroblasts. RESULTS: Capsule specimens from irradiated breast tissue were thicker and had greater CD26-postive cells on immunofluorescence imaging and on fluorescence activated cell sorting analysis than did capsule specimens from the nonirradiated breast. Compared with CD26-negative fibroblasts, CD26-positive fibroblasts produced more collagen and had increased expression of the profibrotic genes IL8, TGF-β1, COL1A1, and TIMP4. CONCLUSIONS: CD26-positive fibroblasts were found in a significantly greater abundance in capsules of irradiated compared with nonirradiated breasts and demonstrated greater fibrotic potential. This fibrogenic fibroblast subpopulation may play an important role in the development of capsular contracture following irradiation, and its targeted depletion or moderation may represent a potential therapeutic option.
BACKGROUND:Breast capsular contracture is a major problem following implant-based breast reconstruction, particularly in the setting of radiation therapy. Recent work has identified a fibrogenic fibroblast subpopulation characterized by CD26 surface marker expression. OBJECTIVES: This work aimed to investigate the role of CD26-positive fibroblasts in the formation of breast implant capsules following radiation therapy. METHODS: Breast capsule specimens were obtained from irradiated and nonirradiated breasts of 10 patients following bilateral mastectomy and unilateral irradiation at the time of expander-implant exchange, under institutional review board approval. Specimens were processed for hematoxylin and eosin staining as well as for immunohistochemistry and fluorescence activated cell sorting for CD26-positive fibroblasts. Expression of fibrotic genes and production of collagen were compared between CD26-positive, CD26-negative, and unsorted fibroblasts. RESULTS: Capsule specimens from irradiated breast tissue were thicker and had greater CD26-postive cells on immunofluorescence imaging and on fluorescence activated cell sorting analysis than did capsule specimens from the nonirradiated breast. Compared with CD26-negative fibroblasts, CD26-positive fibroblasts produced more collagen and had increased expression of the profibrotic genes IL8, TGF-β1, COL1A1, and TIMP4. CONCLUSIONS:CD26-positive fibroblasts were found in a significantly greater abundance in capsules of irradiated compared with nonirradiated breasts and demonstrated greater fibrotic potential. This fibrogenic fibroblast subpopulation may play an important role in the development of capsular contracture following irradiation, and its targeted depletion or moderation may represent a potential therapeutic option.
Authors: Scott L Spear; Mitchel Seruya; Mark W Clemens; Steven Teitelbaum; Maurice Y Nahabedian Journal: Plast Reconstr Surg Date: 2011-03 Impact factor: 4.730
Authors: U M Rieger; J Mesina; D F Kalbermatten; M Haug; H P Frey; R Pico; R Frei; G Pierer; N J Lüscher; A Trampuz Journal: Br J Surg Date: 2013-03-06 Impact factor: 6.939
Authors: Elizabeth I Harper; Tyvette S Hilliard; Emma F Sheedy; Preston Carey; Paul Wilkinson; Michael D Siroky; Jing Yang; Elizabeth Agadi; Annemarie K Leonard; Ethan Low; Yueying Liu; Arya Biragyn; Christina M Annunziata; M Sharon Stack Journal: Aging Cancer Date: 2022-04-19
Authors: Jung Eun Baik; Hyeung Ju Park; Raghu P Kataru; Ira L Savetsky; Catherine L Ly; Jinyeon Shin; Elizabeth M Encarnacion; Michele R Cavali; Mark G Klang; Elyn Riedel; Michelle Coriddi; Joseph H Dayan; Babak J Mehrara Journal: Clin Transl Med Date: 2022-06
Authors: Mimi R Borrelli; Nestor M Diaz Deleon; Sandeep Adem; Ronak A Patel; Shamik Mascharak; Abra H Shen; Dre Irizarry; Dung Nguyen; Arash Momeni; Michael T Longaker; Derrick C Wan Journal: Stem Cells Date: 2019-12-03 Impact factor: 6.277
Authors: Mimi R Borrelli; Abra H Shen; Michelle Griffin; Shamik Mascharak; Sandeep Adem; Nestor M Diaz Deleon; Ledibabari Mildred Ngaage; Michael T Longaker; Derrick C Wan; Hermann Peter Lorenz Journal: Adv Wound Care (New Rochelle) Date: 2021-10-26 Impact factor: 4.947
Authors: Mikkel Morsing; Jiyoung Kim; René Villadsen; Nadine Goldhammer; Abbas Jafari; Moustapha Kassem; Ole William Petersen; Lone Rønnov-Jessen Journal: Breast Cancer Res Date: 2020-09-29 Impact factor: 6.466